Aldawaa Medical Services Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

Group revenue for the quarter reached to SAR 1635.9 million representing a (2.9%) decline, compared to corresponding quarter of the previous year 2025 reflecting softer demand patterns during the period. The Group continued to strengthen its omnichannel proposition, with the online business delivering growth and further increasing its contribution to overall Retail revenue.

The Group continued to accelerate the growth of its other strategic verticals, reinforcing its position across the healthcare value chain and broader ecosystem. Distribution sector revenues increased by 131.1% , driven by the continued expansion of the Distribution business, while Logistics revenues grew by 30%, reflecting the ongoing growth of third-party logistics services. The continued momentum across these businesses demonstrates the Group's ability to capture additional value across the healthcare value chain while further strengthening its integrated healthcare ecosystem.

Net profit for the second quarter of 2026 decreased by SAR 56.3 million compared to the corresponding quarter of the previous year, primarily reflecting the decline in revenue and gross profit. Despite the lower sales, the Group maintained a resilient Retail gross margin of 36.1% during the first half of the year, demonstrating disciplined commercial execution and effective margin management.

The Group maintained a disciplined cost base, with operating expenses remaining broadly flat in absolute terms despite continued strategic investments in digital capabilities, selective Retail expansion, and the ongoing enhancement of its Distribution and Logistics infrastructure. These investments support the Group's long-term strategy of capturing greater value across the healthcare value chain while strengthening its integrated healthcare ecosystem.

The Company recorded during the second quarter of 2026, an increase in revenue by SAR 90.5 million 5.9% compared to the previous quarter. The improvement reflects continued commercial execution across the Group's omnichannel platform, supported by the sustained growth of its strategic verticals, further strengthening its integrated healthcare ecosystem and ability to capture value across the healthcare value chain.

The Company recorded a net profit increase of SAR 8 million 36% during the second quarter of 2026 compared to the previous quarter. The improvement was primarily driven by a 5.9% increase in revenue, coupled with continued cost optimization initiatives, resulting in a reduction of SAR 18.3 million (3.7%) in selling and distribution expenses and general and administrative expenses. This reflects the Company's continued focus on enhancing operational efficiency while maintaining investment in its strategic growth initiatives.

Group revenue for the six-month period of 2026 reached SAR 3181.3 million, representing a (5%) decline, reflecting softer demand patterns in the Retail business during the period. The Group continued to strengthen its omnichannel proposition, with the online business delivering growth and further increasing its contribution to overall Retail revenue.

The Group continued to accelerate the growth of its strategic verticals, reinforcing its position across the healthcare value chain. Distribution sector revenues nearly doubled, increasing by 97.9% , while Logistics revenues grew by 42.8% , reflecting continued business expansion across both segments

Net profit for the first half of 2026 declined compared to the corresponding period of the previous year, primarily reflecting a more competitive operating environment, together with the Group's continued investments in its expansion strategy and strategic infrastructure to support sustainable long-term growth